Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Dentomaxillofac Radiol ; 42(10): 20130302, 2013.
Article in English | MEDLINE | ID: mdl-24174012

ABSTRACT

OBJECTIVES: This study investigated the absorbed doses in a full anthropomorphic body phantom from two different panoramic radiography devices, performing protocols with and without applying a lead apron. METHODS: A RANDO(®) full body phantom (Alderson Research Laboratories Inc., Stamford, CT) was equipped with 110 thermoluminescent dosemeters at 55 different sites and set up in two different panoramic radiography devices [SCANORA(®) three-dimensional (3D) (SOREDEX, Tuusula, Finland) and ProMax(®) 3D (Planmeca, Helsinki, Finland)] and exposed. Two different protocols were performed in the two devices. The first protocol was performed without any lead shielding, whereas the phantom was equipped with a standard adult lead apron for the second protocol. RESULTS: A two-tailed paired samples t-test for the SCANORA 3D revealed that there is no difference between the protocol using lead apron shielding (m = 87.99, s = 102.98) and the protocol without shielding (m = 87.34, s = 107.49), t(54) = -0.313, p > 0.05. The same test for the ProMax 3D showed that there is also no difference between the protocol using shielding (m = 106.48, s = 117.38) and the protocol without shielding (m = 107.75, s = 114,36), t(54) = 0.938, p > 0.05. CONCLUSIONS: In conclusion, the results of this study showed no statistically significant differences between a panoramic radiography with or without the use of lead apron shielding.


Subject(s)
Radiography, Panoramic , Thermoluminescent Dosimetry , Humans , Phantoms, Imaging , Radiation Dosage , Radiation Protection/instrumentation , Radiography, Dental, Digital/instrumentation , Thermoluminescent Dosimetry/instrumentation
2.
Herz ; 38(6): 569-77, 2013 Sep.
Article in German | MEDLINE | ID: mdl-23740085

ABSTRACT

The cardiorenal syndrome is an interdisciplinary challenge with increasing health economic relevance. Renal failure is a strong predictor for mortality in patients with severe congestive heart failure (CHF) and CHF is one of the fastest increasing morbidities in western countries. For successful therapy a close cooperation between cardiology und nephrology is required. Moreover, a good compliance of the patient is needed to improve symptoms and to reduce the frequency of cardiac decompensation. A broad cardiological and nephrological evaluation and consideration of optimal conservative options according to national and international guidelines are essential. However, a renal replacement therapy might be helpful in patients with refractory heart failure even if they are not dialysis-dependent. In cases of acute heart and renal failure an intensive care management might be necessary to reduce volume overload with the help of extracorporeal ultrafiltration or a dialysis modality. Nevertheless, in cases of chronic refractory CHF peritoneal dialysis should be preferred. The first analysis of the registry of the German Society of Nephrology (http://www.herz-niere.de) confirmed that there is a benefit for health-related quality of life in chronic CHF patients treated with peritoneal dialysis.


Subject(s)
Cardio-Renal Syndrome/mortality , Cardio-Renal Syndrome/therapy , Cardiotonic Agents/therapeutic use , Extracorporeal Circulation/mortality , Renal Replacement Therapy/mortality , Cardio-Renal Syndrome/diagnosis , Combined Modality Therapy , Humans , Prevalence , Risk Factors , Treatment Outcome
3.
Dentomaxillofac Radiol ; 42(10): 20130302, 2013.
Article in English | MEDLINE | ID: mdl-24404601

ABSTRACT

OBJECTIVES: This study investigated the absorbed doses in a full anthropomorphic body phantom from two different panoramic radiography devices, performing protocols with and without applying a lead apron. METHODS: A RANDO® full body phantom (Alderson Research Laboratories Inc., Stamford, CT) was equipped with 110 thermoluminescent dosemeters at 55 different sites and set up in two different panoramic radiography devices [SCANORA® three-dimensional (3D) (SOREDEX, Tuusula, Finland) and ProMax® 3D (Planmeca, Helsinki, Finland)] and exposed. Two different protocols were performed in the two devices. The first protocol was performed without any lead shielding, whereas the phantom was equipped with a standard adult lead apron for the second protocol. RESULTS: A two-tailed paired samples t-test for the SCANORA 3D revealed that there is no difference between the protocol using lead apron shielding (m = 87.99, s = 102.98) and the protocol without shielding (m = 87.34, s = 107.49), t(54) = −0.313, p > 0.05. The same test for the ProMax 3D showed that there is also no difference between the protocol using shielding (m = 106.48, s = 117.38) and the protocol without shielding (m = 107.75, s = 114,36), t(54) = 0.938, p > 0.05. CONCLUSIONS: In conclusion, the results of this study showed no statistically significant differences between a panoramic radiography with or without the use of lead apron shielding.


Subject(s)
Radiation Dosage , Radiation Protection/instrumentation , Radiography, Panoramic/instrumentation , Humans , Imaging, Three-Dimensional/instrumentation , Phantoms, Imaging , Radiography, Dental, Digital/instrumentation , Radiography, Panoramic/methods , Thermoluminescent Dosimetry/instrumentation
SELECTION OF CITATIONS
SEARCH DETAIL
...